A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
"This report is a one-stop shop to try to understand the prevalence of kidney disease, how it's being treated and how the burden affects various populations," said researcher Rajesh Balkrishnan, PhD, of the University of Virginia School of Medicine. "If we can identify which treatment modalities are working and how they're used and link these treatments to outcomes, we can inform the government of the most cost-effective ways to manage and treat the growing burden of kidney disease in the U.S."
The massive, two-volume report looks at both chronic kidney disease -- the loss of kidney function over time -- and potentially deadly kidney failure, known as end-stage renal disease. In 2013, Medicare spending for end-stage renal disease increased to $31 billion, in addition to $50 billion spent on chronic kidney disease among those 65 and older.
Balkrishnan, of UVA's Department of Public Health Sciences, led the report's analysis of prescription drug use and cost. His findings include:
Balkrishnan hopes the report will inform national healthcare policy and improve the quality of care for patients with kidney disease. "Our goal is to provide a snapshot view of the major issues in the diagnosis and treatment of kidney disease in the U.S.," Balkrishnan said. "There are definitely gaps there in the treatment of many patients, which can be improved upon."
The above post is reprinted from materials provided by University of Virginia Health System. Note: Materials may be edited for content and length.
Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.
Primary Resource:
Saran, R., Li, Y., Robinson, B., Abbott, K. C., Agodoa, L. Y., Ayanian, J., ... & Eggers, P. W. (2016). US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. American journal of kidney diseases: the official journal of the National Kidney Foundation, 67(3 Suppl 1), A7.
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.